News & Trends - Pharmaceuticals
‘Trust ebbing away’: HTA reforms suffocate under bureaucracy while patients wait
It’s been over two years since the Health Technology Assessment (HTA) Review commenced and more than six months since the […]
MoreNews & Trends - MedTech & Diagnostics
Homegrown medtech returns from global ascent to breathe new life into asthma care in Australia
More than 2.2 million Australians living with asthma could soon benefit from innovative digital inhaler technology, designed not only to […]
MoreNews & Trends - Biotechnology
Government backs industry and research partners in regenerative therapy manufacturing
Australia’s push to lead in regenerative therapy manufacturing has taken a major leap forward with the federal government announcing $65 […]
MoreDigital & Innovation
Reimagining remote care with Australia’s first virtual hospital
Australia’s first virtual hospital is taking on a new role as a national testbed for advancing the future of patient-facing […]
MoreLeadership & Management
Medicines Australia taps cultural strategist to lead communications amid HTA reform push
Medicines Australia has appointed Rachael Coghlan as its new Communications Director, adding to its Executive Team as the organisation ramps […]
MoreESG
Cardinal Health sets new benchmark in sustainability
In an era where sustainability has become a corporate buzzword, Jane Crowe, Managing Director of Cardinal Health ANZ, is pushing […]
MoreHuman Resources
How Australia’s employee engagement measures up
Australia is facing a decline in employee engagement, with just 16% of workers feeling fully engaged in their roles – […]
MoreMedical and Science
Major political parties dismiss research sector warnings
Australia’s major political parties have failed to commit to critical reforms that could determine the survival of the nation’s health […]
MoreCommunication
Mastering the art of saying ‘No’ to protect your career and well-being: Psychologist
As the year draws to a close, professionals and leaders alike are faced with increasing pressure to meet deadlines, complete […]
MoreMarketing & Strategy
Bayer, MSD and Takeda among winners at Asia Pacific awards
Bayer, MSD, Takeda, Alcon, and Cipla emerge as winners among this week’s announcements of Asia Pacific awards which celebrate organisations […]
MoreLatest News in Pharma, MedTech, Diagnostics & Biotech
‘Trust ebbing away’: HTA reforms suffocate under bureaucracy while patients wait
May 1, 2025
in News & Trends - Pharmaceuticals
First targeted therapy for rare lung cancer mutation PBS-listed
May 1, 2025
in News & Trends - Pharmaceuticals
Longer-acting schizophrenia therapy now PBS-listed
May 1, 2025
in News & Trends - Pharmaceuticals
Teva secures PBS listing of motor neurone disease therapy
May 1, 2025
in News & Trends - Pharmaceuticals
Rising tide of misinformation erodes trust in GPs and fuels vaccine hesitancy
May 1, 2025
in News & Trends - Pharmaceuticals
Precision diagnostics to transform management of Crohn’s disease and ulcerative colitis
April 30, 2025
in News & Trends - Pharmaceuticals
Homegrown medtech returns from global ascent to breathe new life into asthma care in Australia
April 30, 2025
in News & Trends - MedTech & Diagnostics
Australian pancreatic cancer device expands global footprint amid local regulatory delays
April 30, 2025
in News & Trends - MedTech & Diagnostics
Major political parties dismiss research sector warnings
April 30, 2025
in Medical and Science
Medicines Australia taps cultural strategist to lead communications amid HTA reform push
April 30, 2025
in Leadership & Management
AbbVie secures PBS listing in aggressive form of blood cancer
April 29, 2025
in News & Trends - Pharmaceuticals
GenesisCare joins oncology partnership in MRI-guided radiation therapy
April 29, 2025
in News & Trends - MedTech & Diagnostics
TGA clears first therapy in rare immunodeficiency disease
April 29, 2025
in News & Trends - Pharmaceuticals
Government backs industry and research partners in regenerative therapy manufacturing
April 29, 2025
in News & Trends - Biotechnology
PBAC greenlights novel cancer and rare disease treatments
April 28, 2025
in News & Trends - Pharmaceuticals
Bureaucracy’s stranglehold on NSW Health: When will the Inquiry report see the light of day?
April 28, 2025
in News & Trends - MedTech & Diagnostics
Breaking a three-decade deadlock: New therapy PBS listed in depression
April 28, 2025
in News & Trends - Pharmaceuticals
Diabetes drug tackles knee osteoarthritis pain, pushing surgery down the line
April 28, 2025
in News & Trends - Pharmaceuticals
Australian medtech eyes IPO after securing regulatory milestone for epilepsy device
April 28, 2025
in News & Trends - MedTech & Diagnostics
Follow Us
Partner with us
News & Trends - Pharmaceuticals
‘Trust ebbing away’: HTA reforms suffocate under bureaucracy while patients wait
It’s been over two years since the Health Technology Assessment (HTA) Review commenced and more than six months since the […]
MoreNews & Trends - Pharmaceuticals
First targeted therapy for rare lung cancer mutation PBS-listed
Australians diagnosed with an aggressive and hard-to-treat form of lung cancer, most common in people who have never smoked, now […]
MoreNews & Trends - Pharmaceuticals
Longer-acting schizophrenia therapy now PBS-listed
From 1 May 2025, Australian adults living with schizophrenia will have access to a long-acting injectable antipsychotic, Abilify Asimtufii (aripiprazole), […]
MoreNews & Trends - Pharmaceuticals
Teva secures PBS listing of motor neurone disease therapy
Teva has welcomed the inclusion of Radicava (edaravone) IV infusion on the Pharmaceutical Benefits Scheme (PBS) for amyotrophic lateral sclerosis […]
More